PharmaPrint, "major" drug firm partnering for herbals line set to debut in July.
This article was originally published in The Tan Sheet
Executive Summary
PHARMAPRINT AND "MAJOR" DRUG FIRM PARTNERING FOR HERBALS LINE of about seven supplements that will roll out to mass market retailers in July, company Chairman and CEO Elliot Friedman told securities analysts at an Oct. 2 session of the Wall Street Forum in New York City. The herbal products will be standardized, guaranteed bioavailable through PharmaPrint's eponymous patented "fingerprinting" technology and carry a pharmaceutical brand name "that everyone knows," Friedman said.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning